维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="Jelacic"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Highly potent,selective,and low cost bis-tetrahydroacridine inhibitors of acetylcholinesterase显示文摘	Quiram P Jelacic T	1996	J Bio Chem1996，271，23：	1
2	The risk of the hemolytic -uremic syndrome after antibiotic treatment of Esheichia Coli O157:H7 infection显示文摘	Jelacic S Habeeb RL	2000	N Engl J Med2000，342，26：	1
3	The risk of the hemolytic - uremic syndrome after antibiotic treatment of Escheichia coli O157 :H 7 infections显示文摘	Craig S Wong MD Srdjan Jelacic BS	2000	New Eng J Med2000，342，：	1
4	Incidence and risk factors for perioperative hyperglycemia in children with traumatic brain injury显示文摘	Sharma D Jelacic J Chennuri R	2009	Anesth Analg2009，108，1：	1
5	Target-controlled do sing of remifentanil during cardiac surgery reduces postoperative hy- peralgesia显示文摘	Richebe P Pouquet O Jelacic S	2011	J Cardiothorae Vase Anesth2011，25，6：	1
6	The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections显示文摘	Wong CS Jelacic S Habeeb RL	2000	N Engl J Med2000，342，：	1
7	Target-controlled dosing of remifentanil during cardiac surgery reduces postoperative hyperalgesia显示文摘	Richebé P Pouquet O Jelacic S		0，，06：	1
8	PKC delta Plays opposite roles in growth mediated by wild -type Kit and an oncogenie Kit mutant显示文摘	Jelacic T Linnekin D	2005	Blood2005，105，5：	1
9	Biocontrol of Escherichia coli O157 with O157-specific bacteriophages 显示文摘	Kudva IT Jelacic S Tarr PI	1999	Appl Environ Microbiol1999，65，9：	1
10	Incidence and risk factors for perioperative hyperglycemia in children with traumatic brain injury显示文摘	Sharma D Jelacic JL Chennuri R	2009	Anesth Analg2009，108，：	1
11	The risk of the he- molytic-uremic syndrome after antibiotic treatment of Esche- richia coli O157 infections显示文摘	Wong C S Jelacic S Habeeb R L	2000	N Eng J Med2000，342，26：	1
12	Endotoxin-induced endothelial cell proinflammatory phenotypic differentiation requires stress fiber polymerization显示文摘	Cuschleri J Gourlay D Garcia I Jelacic S Maier RV	2003	Shock2003，19，5：	1
13	The risk of the hemolytic uremic syndrome after antibiotic Ixeatment of Escheichia coli O157:H7 infections 显示文摘	Wong S Srdjan Jelacic B S Rebecca L H	2000	The New England Journal of Medicine2000，342，：	1
14	Highly potent,selective, and low cost bis-tetrahydroacridine inhibitors of acetylcholinesterase 显示文摘	Pang Y P Quiram P Jelacic T	1996	J Bio Chem1996，271，23：	1
15	Hypertonic saline modulates innate immunity in a model of systemic inflammation 显示文摘	Staudenmayer KL Maier RV Jelacic S	2005	Shock2005，23，5：	1
16	Highly potent,selective,and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase:steps toward novel drugs for treating Alzheimer's disease显示文摘	Pang Y P Quiram P Jelacic T	1996	J Biol Chem1996，271，23：	1
17	The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections 显示文摘	Wong CS Jelacic S Habeeb RL	2000	N Engl J Med2000，342，26：	1
18	Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composedof GIRK2 and GIRK3显示文摘	Jelacic TM Kennedy ME Wickman K	2000	J Biol Chem2000，275，36：	1
19	The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections显示文摘	Wong CS Jelacic S Habeeb RL	2000	N Engl J Med2000，342，26：	1
20	Highly Potent,Selective,and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase Steps toward Novel Drugs for Treating Alzheimer's Disease显示文摘	PANG Y P QUIRAM P JELACIC T	1996	Biol Chem1996，271，23：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示